Clinical Trials for Pharmacosmos

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pharmacosmos

Clinical Trials (10)

NCT06884280
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
PHASE3Not yet recruiting
30 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
3 conditions2 sponsors1 location
NCT06929806
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
PHASE3Recruiting
1,900 participants
Started: May 1, 2025 · Completed: Dec 1, 2027
2 conditions1 sponsor1 location
NCT05545202
A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation
PHASE4Not yet recruiting
150 participants
Started: Apr 30, 2024 · Completed: Feb 15, 2025
2 conditions1 sponsor0 locations
NCT05874401
Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
PHASE4Recruiting
302 participants
Started: Oct 18, 2023 · Completed: Oct 30, 2027
1 condition1 sponsor1 location
NCT05693909
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
PHASE2Recruiting
90 participants
Started: Sep 4, 2023 · Completed: May 31, 2028
2 conditions2 sponsors1 location
NCT05714007
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
PHASE4Recruiting
120 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05179226
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
PHASE3Recruiting
200 participants
Started: Nov 28, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05304442
IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
PHASE3Recruiting
40 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT04945707
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
PHASE4Recruiting
66 participants
Started: Nov 26, 2021 · Completed: May 31, 2026
2 conditions4 sponsors1 location
NCT04913649
Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients
PHASE4Recruiting
310 participants
Started: Sep 23, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations